Peritoneal carcinomatosis in lung cancer: review of the literature with a case report
Article Sidebar
Main Article Content
Abstract
In Colombia for 2020, lung cancer was reported as the fifth neoplasm with the highest incidence and the second with the highest mortality rate. Peritoneal involvement in lung cancer is extremely rare, it is considered <1%. Next, we present a case of peritoneal carcinomatosis in lung cancer in Bogotá, with a subsequent descriptive review of the literature of clinical cases of peritoneal carcinomatosis in lung cancer reported in the world literature in the last 20 years, with the aim of summarizing the main characteristics of these patients that allow to hypothesize their prognostic and therapeutic approach.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
McNeill PM, Wagman LD, Neifeld JP. Small bowel metastases from primary carcinoma of the lung. Cancer 1987;59(8):1486-9.
Quraishi MA, Costanzi JJ, Hokanson J. The natural history of lung cancer with pericardial metastases. Cancer 1983;51(4):740-2.
Hanane K, Salma B, Khadija B et al. Peritoneal carcinomatosis, an unusual and only site of metastasis from lung adenocarcinoma. Pan Afr Med J 2023; 60. Doi: 10.11604/pamj.2016.23.60.8910
Siragusa L, Di Carlo S, Fassari A et al. Therapeutic Strategies and Oncological Outcome of Peritoneal Metastases from Lung Cancer: A Systematic Review and Pooled Analysis. Curr. Oncol 2023; 30: 2928-2941. Doi: 10.3390/curroncol30030224
Satoh H, Ishikawa H, Yamashita Y, Kurishima K, Ohtsuka M, Sekizawa K. Peritoneal carcinomatosis in lung cancer patients. Oncol Rep [Internet]. 1 de noviembre de 2001; 1305-1307. Doi: 10.3892/or.8.6.1305
Kong JH, Lee J, Yi CA et al. Lung metastases in metastatic gastric cancer: pattern of lung metastases and clinical outcome. Gastric Cancer 2012;15(3):292-8.
Patil T, Aisner DL, Noonan SA et al. Malignant pleural disease is highly associated with subsequent peritoneal metastasis in patients with stage IV non-small cell lung cancer independent of oncogene status. Lung Cancer 2016;96:27-32. Doi: 10.1016/j.lungcan.2016.03.007
Sereno M, Rodríguez-Esteban I, Gómez-Raposo C et al. Lung cancer and peritoneal carcinomatosis. Oncology Letters 2013;6(3):705-8.
Nassereddine H, Sannier A, Brosseau S et al. Clinicopathological and Molecular Study of Peritoneal Carcinomatosis Associated with Non-Small Cell Lung Carcinoma. Pathol Oncol Res 2020;26(4):2795-800.
Reis-Filho JS, Carrilho C, Valenti C et al. Is TTF1 a good immunohistochemical marker to distinguish primary from metastatic lung adenocarcinomas? Pathol Res Pract 2000;196(12):835-40. Doi: 10.1016/S0344-0338(00)80084-9.
Fu JX, Wang XJ, Xia M, Wang XJ. Peritoneal carcinomatosis secondary to metastatic lung cancer complicated with acute suppurative appendicitis: A case report and literature review. Medicine 2022;101(49):e31866. Doi: 10.1097/MD.0000000000031866.
Wang Y, Chen B, He Z et al. Nanotherapeutic macrophage-based immunotherapy for the peritoneal carcinomatosis of lung cancer. Nanoscale 2022;14(6):2304-15.
Siracusa L, Di Carlo S, Fassari A et al. Therapeutic Strategies and Oncological Outcome of Peritoneal Metastases from Lung Cancer: A Systematic Review and Pooled Analysis. Curr. Oncol 2023;30(3): 2928-2941. Doi: 10.3390/curroncol30030224
Aarnink A, Fumet JD, Favier L et al. Role of pleural and peritoneal metastasis in immune checkpoint inhibitors efficacy patients with non-small cell lung cancer: real-world data from a large cohort in France. J Cancer Res Clin Oncol 2020; 146: 2699–2707 Doi: 10.1007/s00432-020-03262-2